日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early response evaluation by single cell signaling profiling in acute myeloid leukemia

通过单细胞信号分析评估急性髓系白血病的早期反应

Benedicte Sjo Tislevoll, Monica Hellesøy, Oda Helen Eck Fagerholt, Stein-Erik Gullaksen, Aashish Srivastava, Even Birkeland, Dimitrios Kleftogiannis, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Jørn Skavland, Panagotis Baliakas, Randi Hovland, Vibeke Andresen, Ole Morten Seternes, To

Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling

使用体外药物敏感性分析对急性髓系白血病进行临床预测

Aram N Andersen, Andrea M Brodersen, Pilar Ayuda-Durán, Laure Piechaczyk, Dagim Shiferaw Tadele, Lizet Baken, Julia Fredriksen, Mia Stoksflod, Andrea Lenartova, Yngvar Fløisand, Sigrid S Skånland, Jorrit M Enserink

Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data

利用药物筛选数据对异质性癌细胞群进行表型解卷积

Alvaro Köhn-Luque ,Even Moa Myklebust ,Dagim Shiferaw Tadele ,Mariaserena Giliberto ,Leonard Schmiester ,Jasmine Noory ,Elise Harivel ,Polina Arsenteva ,Shannon M Mumenthaler ,Fredrik Schjesvold ,Kjetil Taskén ,Jorrit M Enserink ,Kevin Leder ,Arnoldo Frigessi ,Jasmine Foo

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

HER2 阳性乳腺癌细胞系的药物筛选和基因组分析揭示了治疗反应的预测因素

Sandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, Eldri Undlien Due, Dagim Shiferaw Tadele, Henrik Edgren, Olli Kallioniemi, Merja Perälä, Gunhild Mari Mælandsmo, Kristine Kleivi Sahlberg